MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$10,619K
EPS
-$0.95
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
License revenue
-
200*
-
Research and development
5,961
-18,749*
15,558
General and administrative
6,118
-12,382*
11,036
Total operating expenses
12,079
-31,131*
26,594
Gain from operations
-12,079
31,331*
-26,594
Interest income (expense)
1,129
2,323*
-96
Other income (expense), net
341
-4,794*
1,837
Total other income (expense), net
1,470
-2,471*
1,741
Gain before income taxes
-10,609
28,860*
-24,853
Income tax expense
10
-128*
-74
Net gain
-10,619
28,988*
-24,779
Accretion of redeemable convertible preferred shares
-
4,508*
846
Net gain attributable to common stockholders
-10,619
24,480
-25,625
Basic EPS
-0.95
20.148
-2.91
Diluted EPS
-0.95
20.148
-2.91
Basic Average Shares
11,211,268
1,215,031
8,526,781
Diluted Average Shares
11,211,268
1,215,031
8,526,781
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
attributable to common...
-$10,619K
Net gain
-$10,619K
Interest income
(expense)
$1,129K
Other income
(expense), net
$341K
Gain before income
taxes
-$10,609K
Income tax expense
$10K
Total other income
(expense), net
$1,470K
Gain from operations
-$12,079K
Total operating
expenses
$12,079K
General and
administrative
$6,118K
Research and development
$5,961K
Buy us a coffee
ImageneBio, Inc. (IMA)
ImageneBio, Inc. (IMA)